Grail price target raised to $20 from $16 at Morgan Stanley

Morgan Stanley analyst Tejas Savant raised the firm’s price target on Grail (GRAL) to $20 from $16 and keeps an Equal Weight rating on the shares following what the firm calls a “solid quarter.” 2025 guidance was in-line with the preliminary view and consistent with prior commentary calling for more moderate screening growth ahead of reimbursement, notes the analyst, who adds that the launch of Galleri v2 expected to lead to significant cost of goods sold improvement over time as test volumes scale.